Use of structurally enhanced fatty acids containing sulphur for preventing and/or treating non-alcoholic steatohepatitis
WO2016120318A1
Enteral feeding device
WO2016156912A1
Use of thia oxo compounds for lowering apo c3
CA2886957A1
Use of thia oxo compounds for lowering apo c3
BR102015007435A2
use of aunt oxo compounds to decrease apo c3
AU2014222389A1
A composition comprising a lipid compound, a triglyceride, and a surfactant, and methods of using the same
AU2014222390A1
Method of preparing 2-((5Z,8Z,11 Z,14Z,17Z)-icosa-5,8,1 1,14,17-pentaenyloxy)butanoic acid
WO2014068056A1
Removal of undesired components from oil compositions
AU2013205154A1
Polyunsaturated fatty acids for the treatment of diseases related to cardiovascular, metabolic and inflammatory disease areas
AU2013203205A1
A process for decreasing environmental pollutants in an oil or a fat, a volatile environmental pollutants de-creasing working fluid, a health supplement, and an animal feed product
EP2833881A1
Compositions comprising omega-3 fatty acids and vitamin d for psoriasis, and methods and uses thereof
WO2013150386A2
Compositions comprising omega-3 fatty acids and vitamin d for acne vulgaris and/or eczema, and methods and uses thereof
TW201343203A
Gelatin/alginate delayed release capsules comprising omega-3 fatty acids, and methods and uses thereof
WO2013072767A1
Compositions and preconcentrates comprising at least one salicylate and omega-3 fatty acid oil mixture
EP2635270A1
Methods of treatment using lipid compounds
AU2011306471A1
Process for concentrating omega-3 fatty acids
TW201311294A
Compositions comprising a fatty acid oil mixture, a surfactant, and a statin
KR20130103521A
Compositions comprising a fatty acid oil mixture, a free fatty acid, and a statin
EP2613766A2
Compositions comprising a fatty acid oil mixture comprising epa and dha in free acid form, a surfactant, and a statin
